Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 127 participants.
Also called NCT01820078
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 127 participants
- Sponsor
- Fundación Renal Iñigo Alvarez De Toledo
- Registry
-
NCT01820078
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Terminated
Technical summary
Registry record NCT01820078. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
- Acronym
- PALIFE
- Condition
- Chronic Kidney Disease, Unspecified
- Intervention (Drug)
- Experimental arm
- Intervention (Other)
- Comparator Arm
- Lead sponsor
- Fundación Renal Iñigo Alvarez De Toledo
- Collaborator
- Effice Servicios Para la Investigacion S.L.
Record details
- Record id
cardio:ct-nct01820078- Content hash
a1cbcbea490a99e40a558ce6ccbb7c09a06d3ba2b28b99a92ce7fbb03abd4a18